National Cancer Institute reported risk of lymphoma increases with Hepatitis C virus infection
On May 8, 2007, the National Cancer Institute (NCI) reported that people infected with the hepatitis C virus…
FDA approved the H5N1 vaccine, the first vaccine approved for avian flu
On Apr. 17, 2007, Sanofi announced that the U.S. Food and Drug Administration (FDA) had licensed its H5N1…
FDA approved an accelerated dosing schedule for Twinrix (hepatitis A and B vaccine)
On Mar. 28, 2007, the U.S. Food and Drug Administration (FDA) announced that GlaxoSmithKline (King of Prussia, Pennsylvania)…
Livermore Lab developed pathogen signatures for bioterrorist attack Identification
In 2007, researchers at Livermore National Laboratory announced they had developed candidate signatures for pathogens that might be…
Lethal infection of K18-hACE2 mice infected with Severe Acute Respiratory Syndrome Coronavirus published
In January 2007, scientists at the University of Iowa reported in the Journal of Virology that they had…
Cocrystal Discovery (Cocrystal Pharma) was founded
In 2007, Cocrystal Discovery, now known as Cocrystal Pharma, was founded in Bothell as a pharmaceutical company with…
The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
Sanofi Pasteur delivered H5N1 vaccine for U.S. government pandemic initiatives
On Feb. 6, 2006, Sanofi pasteur announced it had delivered more H5N1 vaccine to the U.S. government including…
Rotavirus vaccine, live, oral, pentavalent was licensed for use in infants ages 6 to 32 weeks
On Feb. 3, 2006, Rotavirus vaccine, live, oral, pentavalent (RotaTeq by Merck) was licensed for use in infants…
The CDC’s advisory Committee recommended routine immunizations for children and adolescents of rotavirus and HPV
On Jan. 6, 2006, the U.S. Centers for Disease Control and Prevention’s (CDC) advisory Committee on Immunization Practices…
The Kansas State University Biosecurity Research Institute was dedicated
In 2006, the Kansas State University Biosecurity Research Institute dedicated the Biosecurity Research Institute (BRI) that was designed…
Malaria Atlas Project was founded
In 2006, the Malaria Atlas Project (MAP) was founded as an international research collaboration that tracks the global…
The CDC activated its Emergency Operations Center for Tropical Storm Ernesto
Aug. 24, 2024, the U.S. Centers for Disease Control and Prevention (CDC) activated its Emergency Operations Center (EOC)…
CDC’s ACIP updated immunization strategy to eliminate transmission of Hepatitis B Virus infection in the U.S.
On Dec. 23, 2005, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
Final order on the anthrax vaccine was issued by FDA
On Dec. 19, 2005, in a 2-year legal battle over the U.S. military’s anthrax vaccination program, the Food…
The Bill & Melinda Gates Foundation announced grants totaling $258 million to develop a malaria vaccine
On Oct. 30, 2005, the Bill & Melinda Gates Foundation announced three grants totaling $258.3 million for advanced…
A vaccine that combined the measles, mumps, rubella, and varicella antigens was licensed
On Sept. 6, 2005, the vaccine that combined the measles, mumps, rubella, and varicella antigens (Proquad by Merck)…
An inactivated, injectable influenza vaccine was licensed
On Aug. 31, 2005, the inactivated, injectable influenza vaccine (Fluarix) by GlaxoSmithKline (GSK) was licensed. The vaccine was…
FDA approved lowering the age limit to 12 mos for one of the two licensed hepatitis A vaccine
On Aug. 11, 2005, the Food and Drug Administration (FDA) approved an application of a pediatric/adolescent formulation of…
FDA licensed a 2nd Tdap vaccine (Adacel by Sanofi Pasteur) for use in persons ages 11-64 years
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) licensed a 2nd Tdap vaccine (Adacel by…
Sanofi Pasteur announced FDA approval of Menactra meningococcal conjugate vaccine indication for infants
On Apr. 22, 2005, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had granted licensure to…
HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.
On Apr. 1, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Department of…
CDC announced that rubella was no longer endemic in the U.S.
On Mar. 21, 2005, the U.S. Centers for Disease Control and Prevention (CDC) announced that a major public…
UCLA launched $20 million stem cell institute to investigate new approaches to HIV, cancer and neurological disorders
On Mar. 16, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
The CDC assisted with the public health response to the devastating tsunami in the Indian Ocean
On Dec. 26, 2004, the U.S. Centers for Disease Control and Prevention (CDC) assisted with an earthquake measuring…
OHSU was awarded $4 million NIH biodefense contract to study tuberculosis
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
OHSU announced collaboration with PNNL on biodefense project studying salmonella, pox viruses
On Sept. 14, 2004, researchers at OHSU and OHSU’s Vaccine and Gene Therapy Institute announced a collaboration with…
A significant shortage of influenza vaccine occurred in the U.S.
On Aug. 25, 2004, a significant shortage of influenza vaccine occurred in the U.S. as a result of…
Biotechnology | Chemistry | Diagnostics | FDA | Infectious Disease | Radiology | Therapeutics | U.S. Congress
Project BioShield Act authorized FDA to expedite review procedures for treatments for chemical, biological and nuclear agents
On Jul. 21, 2004, Project BioShield Act of 2004 was signed by President George W. Bush. The Act…
OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…